Training program for pediatric cancer immunotherapy researchers

T32 Training Program in Pediatric Immuno-Oncology and Immunotherapy

NIH-funded research St. Jude Children's Research Hospital · NIH-10914981

This program is designed to help new researchers learn how to create safer and more effective treatments for kids with cancer by focusing on using the body's immune system to fight the disease.

Quick facts

Grant typeTraining grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital NIH-funded
Lab location1 site (Memphis, United States)
Project IDNIH-10914981 on NIH RePORTER

What this research studies

This program aims to train postdoctoral fellows in the field of pediatric immuno-oncology and immunotherapy, equipping them with the necessary skills to advance treatment for pediatric cancer patients. The focus is on developing immunotherapies that can specifically target cancer cells while minimizing toxicity and long-term side effects. By fostering a new generation of researchers, the program seeks to enhance the understanding of the immune landscape in pediatric cancers and facilitate the translation of these therapies into clinical practice. This initiative addresses a critical gap in pediatric cancer research training.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research are pediatric cancer patients who may be eligible for innovative immunotherapy treatments.

Not a fit: Patients with adult cancers or those not diagnosed with cancer may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective and less toxic treatments for pediatric cancers that are currently difficult to treat.

How similar studies have performed: While there has been significant success in adult immunotherapy research, this program is pioneering in its focus on pediatric immuno-oncology, making it a novel initiative.

Where this research is happening

Memphis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.